Company: ARWR
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001628280-25-024666
Chunk: 65

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 65
---
 and other 10,815 37 %6,278 25 %4,537 72 %Facilities related1,082 4 %1,015 4 %67 7 %Total general & administrative expense, excluding non-cash expenses$19,754 69 %$14,381 57 %$5,373 37 %Stock compensation8,140 29 %10,263 41 %(2,123)(21)%Depreciation and amortization511 2 %425 2 %86 20 %Total general & administrative expenses$28,405 100 %$25,069 100 %$3,336 13 %

(in thousands)Six Months Ended March 31, 2025% ofExpenseCategory Six Months Ended March 31, 2024% ofExpenseCategory Increase (Decrease)$% Salaries$15,188 27 %$13,347 27 %$1,841 14 %Professional, outside services, and other20,941 38 %11,500 24 %9,441 82 %Facilities related2,367 4 %2,040 4 %327 16 %Total general & administrative expense, excluding non-cash expense$38,496 69 %$26,887 55 %$11,609 43 %Stock compensation15,799 29 %20,950 43 %(5,151)(25)%Depreciation and amortization1,020 2 %837 2 %183 22 %Total general & administrative expense$55,315 100 %$48,674 100 %$6,641 14 %

Salaries expense increased $0.8 million, or 11%, for the three months ended March 31, 2025 and $1.8 million, or 14%, for the six months ended March 31, 2025 compared to the same periods of 2024. The increase was driven by the combination of annual salary increases and increased headcount required to support the Company’s growth. 

Professional, outside services, and other expenses include costs related to legal, audit, consulting, patent filings, business insurance, other external services, as well as travel, communication, and technology expenses. This expense increased $4.5 million, or 72%, for the